Contralateral Aloe-Glove Study in 29 Assembly-Line Workers
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: What can a contralateral 29-worker glove study show—and why can its result not be transferred to #003?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 30 adult female assembly-line workers with bilateral occupational dry skin or irritant contact dermatitis; 29 were evaluable. |
| Design | Open, within-person contralateral comparison of an aloe-coated latex glove on one hand versus no glove on the other. |
| Comparator | Each participant’s treated hand was compared with her untreated hand; treatment assignment was not blinded or randomized. |
| Timepoint | Glove use eight hours daily for 30 days, 30 days of rest, then 10 days of reuse. |
| Key result | The aloe-glove hand showed first noticeable improvement after a mean 3.5 days and marked improvement after 10.4 days; untreated hands showed no improvement. Blinded end-study photo scores averaged 1.3 versus 0 (p<0.0001). |
| Funding/conflict context | The indexed abstract does not state funding or conflict disclosures. This was a different aloe-delivering glove product; its results cannot be transferred to Dr. Arsy #003. |
What was actually measured?
The aloe-glove hand showed first noticeable improvement after a mean 3.5 days and marked improvement after 10.4 days; untreated hands showed no improvement. Blinded end-study photo scores averaged 1.3 versus 0 (p<0.0001).
The within-person design controls some individual differences, but the open, small study cannot separate the coating, occlusion, behavior and expectation effects.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
Small all-female single-workplace sample, nonrandomized unblinded use, short follow-up and a specialized glove product limit generalizability.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 12548256
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Six-Month Outcomes in 1,048 Occupational-Skin Patients
- Recognized Occupational Dermatitis in 381 Danish Hairdressers
- Skin Reports in 114 TDI Foam-Plant Workers
- Hand Eczema in 504 Hairdressing Apprentices and 1,400 Controls
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.